Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Filings indexed 916 across all filing types
Latest filing 2017-03-21 Regulatory Filings
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
STADA postpones press and analyst conference on full year figures 2016 to March 29, 2017
Regulatory Filings Classification · 99% confidence The document is a short news release dated March 21, 2017, announcing the postponement of the press and analyst conference for the full-year figures of 2016. It mentions a reassessment impacting potential figures but states no material change is expected in the final figures. Since this is an announcement about the scheduling of an event (the earnings conference) and not the transcript of the call itself (CT) or the full annual report (10-K), and it is a general corporate news item distributed via DGAP, it fits best under the general Regulatory Filings category (RNS) as it is a miscellaneous corporate announcement that doesn't fit the more specific categories like ER (Earnings Release, which usually contains the actual results) or RPA (Report Publication Announcement, which usually announces the publication of a formal report, not the rescheduling of a conference about it). Given the short length and nature as a scheduling update, RNS is the most appropriate fallback.
2017-03-21 English
STADA Arzneimittel AG: STADA raises medium-term growth targets
Earnings Release Classification · 95% confidence The document is an 'Ad hoc Release' dated March 17, 2017, announcing that STADA Arzneimittel AG is raising its medium-term growth targets for 2019 (sales, EBITDA, net income). This type of announcement, which details changes in financial outlook or forecasts outside of a standard periodic report (like 10-K or IR), is typically classified as an Earnings Release (ER) if it contains key financial highlights, or sometimes as a Regulatory Filing (RNS) if it's a general market disclosure. Since it explicitly details revised financial targets (sales, EBITDA, net income) and is labeled as an 'Ad hoc Release' concerning financial performance updates, it aligns best with the 'Earnings Release' (ER) definition, which covers initial announcements of periodical financial results or significant updates to guidance. Although it's not a standard quarterly earnings report, it functions as a material financial guidance update. Given the options, ER is the most appropriate fit for a material financial forecast change announcement. FY 2019
2017-03-17 English
STADA Arzneimittel AG: STADA: Statement on media reports
M&A Activity Classification · 99% confidence The document is a short announcement (2480 characters) issued via DGAP, stating that STADA Arzneimittel AG is confirming media reports regarding the postponement of expert sessions in a structured bidding process because indicative bids did not reflect the fundamental value. This is a specific corporate update concerning strategic activities (potential sale/bidding) and is not a standard periodic report (10-K, IR), an earnings release (ER), or a formal legal filing. Since it addresses a specific corporate event (bidding process status) but doesn't fit perfectly into M&A Activity (TAR) which usually covers the proposal/bid itself, or a financing update (CAP), the most appropriate general category for a non-standard, timely corporate statement disseminated via a news service like DGAP is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate news that doesn't fit other specific categories, especially when it's a 'Statement on media reports'. Given the context of strategic corporate activity, RNS is the best fit among the provided options for a general news release.
2017-03-16 English
Report Publication Announcement 2017
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that it is announcing *when* future financial reports (Q1 and Q3 reports) will be disclosed, providing future dates and links to where those reports will eventually reside. This structure—announcing the publication of other reports rather than containing the full report itself—fits the definition of a Report Publication Announcement (RPA). The document length is short (1777 chars), further supporting the 'announcement' classification over the actual report (like IR or ER).
2017-03-16 English
Report Publication Announcement 2017
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports..." and explicitly states that several reports (Annual financial report, Group annual financial report, Group financial report (half-year/Q2)) *shall be disclosed* on future dates (March 23, 2017, and August 03, 2017), providing links to where they will be available. This structure—announcing the future release of official reports—perfectly matches the definition of a Report Publication Announcement (RPA). The document itself is not the full financial report (10-K or IR), but a notice about its upcoming release, adhering to the 'MENU VS MEAL' rule.
2017-03-16 English
Hinweis auf Jahresfinanzbericht vom 01.01.2016 bis zum 31.12.2016
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 800 characters) that informs shareholders about the availability of the 2016 Annual Financial Report. It provides a link to the report and specifies the publication date. Per the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2017-03-16 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.